Labisto, Roy A.

HRN: 27-36-73  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2025
CLINDAMYCIN 300MG (CAP)
06/20/2025
06/27/2025
PO
300mg
Q6h
CELLULITIS
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: